Search

Background: Refractory angina is a growing and major health-care problem affecting millions of patients with coronary artery disease worldwide. The Coronary Sinus Reducer (CSR) is a device that may be considered for the relief of symptoms of refractory angina. It causes increased venous pressure leading to a dilatation of arterioles and reduced arterial vascular resistance in the sub-endocardium. This study describes the 5‑year Dutch experience regarding safety and efficacy of the CSR. Methods: One hundred and thirty-two patients with refractory angina were treated with the CSR. The primary efficacy endpoint of the study was Canadian Cardiovascular Society (CCS) class improvement between baseline and 6‑month follow-up. The primary safety endpoint was successful CSR implantation in the absence of any device-related events. Results: Eighty-five patients (67%) showed improvement of at least 1 CCS class and 43 patients (34%) of at least 2 classes. Mean CCS class improved from 3.17 ± 0.61 to 2.12 ± 1.07 after implantation (P < 0.001). The CSR was successfully implanted in 99% of the patients and only minor complications during implantation were reported. Conclusion: The CSR is a simple, safe, and effective option for most patients with refractory angina. However, approximately thirty percent of the patients showed no benefit after implantation. Future studies should focus on the exact underlying mechanisms of action and reasons for non-response to better identify patients that could benefit most from this therapy. [ABSTRACT FROM AUTHOR]

Soil organic matter (SOM) is declining in most agricultural ecosystems, impacting multiple ecosystem services including erosion and flood prevention, climate and greenhouse gas regulation as well as other services that underpin crop production, such as nutrient cycling and pest control. Ecological intensification aims to enhance crop productivity by including regulating and supporting ecosystem service management into agricultural practices. We investigate the potential for increased SOM to support the ecological intensification of arable systems by reducing the need for nitrogen fertiliser application and pest control. Using a large-scale European field trial implemented across 84 fields in 5 countries, we tested whether increased SOM (using soil organic carbon as a proxy) helps recover yield in the absence of conventional nitrogen fertiliser and whether this also supports crops less favourable to key aphid pests. Greater SOM increased yield by 10%, but did not offset nitrogen fertiliser application entirely, which improved yield by 30%. Crop pest responses depended on species: Metopolophium dirhodum were more abundant in fertilised plots with high crop biomass, and although population growth rates of Sitobion avenae were enhanced by nitrogen fertiliser application in a cage trial, field populations were not affected. We conclude that under increased SOM and reduced fertiliser application, pest pressure can be reduced, while partially compensating for yield deficits linked to fertiliser reduction. If the benefits of reduced fertiliser application and increased SOM are considered in a wider environmental context, then a yield cost may become acceptable. Maintaining or increasing SOM is critical for achieving ecological intensification of European cereal production. [ABSTRACT FROM AUTHOR]

In patients with chronic myeloid leukemia (CML) who do not reach a (near) complete cytogenetic response, the disease progresses over several years from an indolent, chronic phase into a rapidly fatal blast crisis. Events that are responsible for this transformation process are largely unknown. To identify changes in gene expression that occurred during the course of the disease, we performed cDNA subtraction on sequentially stored peripheral blood mononuclear cell pellets, collected throughout the course of disease of a single CML patient. In total, 32 differentially expressed sequences were identified, of which 27 corresponded to known genes. On quantitative PCR, eight of these genes, YWHAZ, GAS2, IL8, IL6, PBEF1, CCL4, SAT and MMRN, showed comparable differential expression in additional CML patient samples. This set of genes can be considered as a starting point for further research on causes of disease transformation in CML and may lead to new targets in the treatment of resistant CML.Leukemia (2005) 19, 998-1004. doi:10.1038/sj.leu.2403735 Published online 7 April 2005 [ABSTRACT FROM AUTHOR]

Based on the amino acid sequence of the molt-inhibiting hormone of Carcinus maenas, two degenerated oligonucleotide primers were synthesized and used in the polymerase chain reaction. By use of complementary DNA of a library constructed from medulla terminalis-X-organ RNA of C. maenas as template, the specific complementary DNA between the primers was amplified, cloned and sequenced. This strategy revealed a DNA sequence for which the deduced amino acid sequence is identical to the recently published C. maenas molt-inhibiting hormone sequence as determined by Edman degradation. Visualization of messenger RNAs encoding molt-inhibiting hormone and crustacean hyperglycemic hormone in different perikarya of the X-organ was obtained using digoxigenin-labelled complementary RNA probes. Combination of immunocytochemical staining using polyclonal antisera against the native C. maenas neuropeptides and in situ hybridization performed on alternating sections confirmed the specificity of the reaction. The results show that there is no co-localization of molt-inhibiting hormone and crustacean hyperglycemic hormone at the messenger RNA and the protein level. [ABSTRACT FROM AUTHOR]